IL10 and irritable bowel syndrome: Additionally, an earlier study on irritable bowel syndrome (IBS) [46] revealed beneficial systemic and immunomodulatory effects of probiotics, with a notable normalization of the interleukin-10 to interleukin-12 ratio observed exclusively in IBS patients treated with Bifidobacterium infantis 35624.